Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Algorithm Information

Irinotecan Dosage Adjustment for Colon Cancer and Hepatic Dysfunction

MyLikes

MyPaths
Purpose:
To adjust the recommended dose of irinotecan for a patient with colon cancer based on the level of hepatic dysfunction as reported by Raymond et al.
Specialty
  • Hematology Oncology
    Surgery
  • General
Objective
  • Dosage adjustments
ICD-10
  • C18
  • C19
  • C20
  • K76.8

In order to access the algorithms, please subscribe to a plan that fits your needs.

MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Irinotecan Dosage Adjustment for Colon Cancer and Hepatic Dysfunction
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.